Clinical Trials Browser

Phase 2 × Palonosetron × 1 year × Clear all

NCT06904235 2025-07-28

Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)

Phase 2 Recruiting

Nausea, Vomiting

NCT04592198 2025-03-24

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Phase 2 Completed

22 enrolled 8 charts

Nausea With Vomiting Chemotherapy-Induced